Lahore: Citi Pharma Ltd. has scheduled a board meeting on October 29, 2025, at 1:30 PM in Lahore to review the company's quarterly accounts for the period ending September 30, 2025. The meeting will also consider the declaration of any entitlements for shareholders.

The company has declared a closed period from October 23 to October 29, 2025, in compliance with section 5.6.1(d) of Pakistan Stock Exchange (PSX) Regulations. During this time, no director, CEO, or executive of Citi Pharma Ltd. will be permitted to deal in the company's shares, either directly or indirectly.

According to information available from the Pakistan Stock Exchange (PSX), the announcement of a closed period is a standard regulatory requirement intended to prevent insider trading and ensure fair market practices. Shareholders and certificate holders have been notified of these developments accordingly.